Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-047111
Filing Date
2025-03-31
Accepted
2025-03-28 21:08:30
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tsbx-20241231.htm   iXBRL 10-K 3687508
2 EX-4.3 tsbx-ex4_3.htm EX-4.3 38391
3 EX-10.16 tsbx-ex10_16.htm EX-10.16 62040
4 EX-10.17 tsbx-ex10_17.htm EX-10.17 73690
5 EX-23.1 tsbx-ex23_1.htm EX-23.1 5178
6 EX-31.1 tsbx-ex31_1.htm EX-31.1 13766
7 EX-31.2 tsbx-ex31_2.htm EX-31.2 13909
8 EX-32.1 tsbx-ex32_1.htm EX-32.1 9358
9 EX-97.1 tsbx-ex97_1.htm EX-97.1 43362
  Complete submission text file 0000950170-25-047111.txt   13842452

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20241231.xsd EX-101.SCH 1828898
95 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20241231_htm.xml XML 2346598
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41747 | Film No.: 25788447
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)